Gabriele Neumann
31Patents
13h-index
8Co-inventors
74Inventor score
Filing activity: Mar 24, 1997 → Jul 18, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7968101B2 | Recombinant influenza vectors with tandem transcription units | Emerging Cross-Sectional Technologies | 36 | Expired |
| US9950057B2 | High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs | Chemistry; Metallurgy | 23 | Active |
| US9890363B2 | Influenza virus replication for vaccine development | Chemistry; Metallurgy | 20 | Active |
| US10172934B2 | High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs | Chemistry; Metallurgy | 19 | Active |
| US9101653B2 | Influenza viruses with mutant PB2 gene segment as live attenuated vaccines | Physics | 17 | Active |
| US7211378B2 | Filovirus vectors and noninfectious filovirus-based particles | Emerging Cross-Sectional Technologies | 17 | Expired |
| US10246686B2 | Influenza virus replication for vaccine development | Chemistry; Metallurgy | 17 | Active |
| US8900595B2 | Filovirus vectors and noninfectious filovirus-based particles | Emerging Cross-Sectional Technologies | 16 | Active |
| US10513692B2 | Influenza viruses with mutant PB2 segment as live attenuated vaccines | Physics | 15 | Active |
| US10494613B2 | Generation of infectious influenza viruses from virus-like particles | Chemistry; Metallurgy | 15 | Active |
| US10633422B2 | Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA | Chemistry; Metallurgy | 15 | Active |
| US8877209B2 | Recombinant influenza vectors with tandem transcription units | Emerging Cross-Sectional Technologies | 14 | Active |
| US11389523B2 | Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein | Chemistry; Metallurgy | 13 | Active |
| US11197925B2 | Influenza B virus replication for vaccine development | Chemistry; Metallurgy | 13 | Active |
| US10358630B2 | Recombinant influenza vectors with tandem transcription units | Emerging Cross-Sectional Technologies | 13 | Active |
| US11390649B2 | Influenza virus replication for vaccine development | Chemistry; Metallurgy | 13 | Active |
| US11180737B2 | Generation of infectious influenza viruses from virus-like particles | Chemistry; Metallurgy | 13 | Active |
| US11384339B2 | Influenza viruses with mutant PB2 gene segment as live attenuated vaccines | Physics | 13 | Active |
| US6524588B1 | Attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus | Chemistry; Metallurgy | 5 | Expired |
| US12122807B2 | Influenza virus replication for vaccine development | Chemistry; Metallurgy | 2 | Active |
| US12290562B2 | Recombinant multivalent influenza viruses | Chemistry; Metallurgy | 2 | Active |
| US12144857B2 | Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein | Chemistry; Metallurgy | 2 | Active |
| US8715940B2 | Method of making recombinant influenza virus | Chemistry; Metallurgy | 1 | Active |
| US8877448B2 | Method of making recombinant influenza virus | Chemistry; Metallurgy | 1 | Active |
| US8859208B2 | System producing infectious recombinant influenza virus | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.